Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Natural melanoma-derived extracellular vesicles.

Hood JL.

Semin Cancer Biol. 2019 Aug 3. pii: S1044-579X(19)30003-3. doi: 10.1016/j.semcancer.2019.06.020. [Epub ahead of print] Review.

PMID:
31386906
2.

Detection of Inflammation-Related Melanoma Small Extracellular Vesicle (sEV) mRNA Content Using Primary Melanocyte sEVs as a Reference.

Bardi GT, Al-Rayan N, Richie JL, Yaddanapudi K, Hood JL.

Int J Mol Sci. 2019 Mar 12;20(5). pii: E1235. doi: 10.3390/ijms20051235.

3.

Pre-analytical influences on the population heterogeneity of human extracellular vesicles sourced for nanomedicine uses.

Hood JL.

Nanomedicine (Lond). 2018 Nov;13(21):2669-2674. doi: 10.2217/nnm-2018-0287. Epub 2018 Oct 26. No abstract available.

4.

Exosome Isolation: Cyclical Electrical Field Flow Fractionation in Low-Ionic-Strength Fluids.

Petersen KE, Shiri F, White T, Bardi GT, Sant H, Gale BK, Hood JL.

Anal Chem. 2018 Nov 6;90(21):12783-12790. doi: 10.1021/acs.analchem.8b03146. Epub 2018 Oct 22.

PMID:
30346136
5.

Melanoma exosomes promote mixed M1 and M2 macrophage polarization.

Bardi GT, Smith MA, Hood JL.

Cytokine. 2018 May;105:63-72. doi: 10.1016/j.cyto.2018.02.002. Epub 2018 Feb 17.

6.

The association of exosomes with lymph nodes.

Hood JL.

Semin Cell Dev Biol. 2017 Jul;67:29-38. doi: 10.1016/j.semcdb.2016.12.002. Epub 2016 Dec 2. Review.

PMID:
27916565
7.
8.

Post isolation modification of exosomes for nanomedicine applications.

Hood JL.

Nanomedicine (Lond). 2016 Jul;11(13):1745-56. doi: 10.2217/nnm-2016-0102. Epub 2016 Jun 27. Review.

9.

Melanoma exosomes enable tumor tolerance in lymph nodes.

Hood JL.

Med Hypotheses. 2016 May;90:11-3. doi: 10.1016/j.mehy.2016.02.018. Epub 2016 Feb 27.

10.

A review of exosome separation techniques and characterization of B16-F10 mouse melanoma exosomes with AF4-UV-MALS-DLS-TEM.

Petersen KE, Manangon E, Hood JL, Wickline SA, Fernandez DP, Johnson WP, Gale BK.

Anal Bioanal Chem. 2014 Dec;406(30):7855-66. doi: 10.1007/s00216-014-8040-0. Epub 2014 Aug 2. Review.

11.

Magnetic resonance imaging of melanoma exosomes in lymph nodes.

Hu L, Wickline SA, Hood JL.

Magn Reson Med. 2015 Jul;74(1):266-271. doi: 10.1002/mrm.25376. Epub 2014 Jul 22.

12.

Reovirus-mediated induction of ADAR1 (p150) minimally alters RNA editing patterns in discrete brain regions.

Hood JL, Morabito MV, Martinez CR 3rd, Gilbert JA, Ferrick EA, Ayers GD, Chappell JD, Dermody TS, Emeson RB.

Mol Cell Neurosci. 2014 Jul;61:97-109. doi: 10.1016/j.mcn.2014.06.001. Epub 2014 Jun 4.

13.

Nanoparticle incorporation of melittin reduces sperm and vaginal epithelium cytotoxicity.

Jallouk AP, Moley KH, Omurtag K, Hu G, Lanza GM, Wickline SA, Hood JL.

PLoS One. 2014 Apr 18;9(4):e95411. doi: 10.1371/journal.pone.0095411. eCollection 2014.

14.

Maximizing exosome colloidal stability following electroporation.

Hood JL, Scott MJ, Wickline SA.

Anal Biochem. 2014 Mar 1;448:41-9. doi: 10.1016/j.ab.2013.12.001. Epub 2013 Dec 9.

15.

Cytolytic nanoparticles attenuate HIV-1 infectivity.

Hood JL, Jallouk AP, Campbell N, Ratner L, Wickline SA.

Antivir Ther. 2013;18(1):95-103. doi: 10.3851/IMP2346. Epub 2012 Sep 6.

PMID:
22954649
16.

Burnout among workers in a pediatric health care system.

Jacobs LM, Nawaz MK, Hood JL, Bae S.

Workplace Health Saf. 2012 Aug;60(8):335-44. doi: 10.3928/21650799-20120726-03.

PMID:
22850134
17.

A systematic approach to exosome-based translational nanomedicine.

Hood JL, Wickline SA.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2012 Jul-Aug;4(4):458-67. doi: 10.1002/wnan.1174. Epub 2012 May 30. Review.

PMID:
22648975
18.

Editing of neurotransmitter receptor and ion channel RNAs in the nervous system.

Hood JL, Emeson RB.

Curr Top Microbiol Immunol. 2012;353:61-90. doi: 10.1007/82_2011_157. Review.

19.

Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis.

Hood JL, San RS, Wickline SA.

Cancer Res. 2011 Jun 1;71(11):3792-801. doi: 10.1158/0008-5472.CAN-10-4455. Epub 2011 Apr 8.

20.

The solution structure of the ADAR2 dsRBM-RNA complex reveals a sequence-specific readout of the minor groove.

Stefl R, Oberstrass FC, Hood JL, Jourdan M, Zimmermann M, Skrisovska L, Maris C, Peng L, Hofr C, Emeson RB, Allain FH.

Cell. 2010 Oct 15;143(2):225-37. doi: 10.1016/j.cell.2010.09.026.

21.

Mice with altered serotonin 2C receptor RNA editing display characteristics of Prader-Willi syndrome.

Morabito MV, Abbas AI, Hood JL, Kesterson RA, Jacobs MM, Kump DS, Hachey DL, Roth BL, Emeson RB.

Neurobiol Dis. 2010 Aug;39(2):169-80. doi: 10.1016/j.nbd.2010.04.004. Epub 2010 Apr 13.

22.

Lipid membrane editing with peptide cargo linkers in cells and synthetic nanostructures.

Pan H, Myerson JW, Ivashyna O, Soman NR, Marsh JN, Hood JL, Lanza GM, Schlesinger PH, Wickline SA.

FASEB J. 2010 Aug;24(8):2928-37. doi: 10.1096/fj.09-153130. Epub 2010 Mar 24.

23.

Paracrine induction of endothelium by tumor exosomes.

Hood JL, Pan H, Lanza GM, Wickline SA; Consortium for Translational Research in Advanced Imaging and Nanomedicine (C-TRAIN).

Lab Invest. 2009 Nov;89(11):1317-28. doi: 10.1038/labinvest.2009.94. Epub 2009 Sep 28.

24.

Life-threatening organ failure after lamotrigine therapy.

Ferguson LP, Dargan PI, Hood JL, Tibby SM.

Pediatr Neurol. 2009 May;40(5):392-4. doi: 10.1016/j.pediatrneurol.2008.11.018.

PMID:
19380079
25.

Evaluation of a prolonged prothrombin time.

Hood JL, Eby CS.

Clin Chem. 2008 Apr;54(4):765-8; discussion 768-9. doi: 10.1373/clinchem.2007.100818. No abstract available.

26.

Subcellular mobility of the calpain/calpastatin network: an organelle transient.

Hood JL, Brooks WH, Roszman TL.

Bioessays. 2006 Aug;28(8):850-9. Review.

PMID:
16927317
27.

Differential compartmentalization of the calpain/calpastatin network with the endoplasmic reticulum and Golgi apparatus.

Hood JL, Brooks WH, Roszman TL.

J Biol Chem. 2004 Oct 8;279(41):43126-35. Epub 2004 Aug 9.

28.

Association of the calpain/calpastatin network with subcellular organelles.

Hood JL, Logan BB, Sinai AP, Brooks WH, Roszman TL.

Biochem Biophys Res Commun. 2003 Oct 31;310(4):1200-12.

PMID:
14559243
29.

Effectiveness of the neonatal transport team.

Hood JL, Cross A, Hulka B, Lawson EE.

Crit Care Med. 1983 Jun;11(6):419-23.

PMID:
6851597
30.

Behavioral alterations produced by chronic naloxone injections.

Malin DH, Layng MP, Swank P, Baker MJ, Hood JL.

Pharmacol Biochem Behav. 1982 Sep;17(3):389-92.

PMID:
6890681
31.

A severe infantile sialidosis: clinical, biochemical, and microscopic features.

Aylsworth AS, Thomas GH, Hood JL, Malouf N, Libert J.

J Pediatr. 1980 Apr;96(4):662-8.

PMID:
7359270
32.

A community hospital looked at its clinic service.

Hood JL.

Hosp Manage. 1967 Apr;103(4):48-50. No abstract available.

PMID:
6046109

Supplemental Content

Support Center